FDA Advises Virtual Ban On Amgen, J&J Anemia Drugs
A U.S. Food and Drug Administration panel reportedly voted Thursday to ban the use of anemia drugs, including Amgen Inc.'s Aranesp and Epogen and Johnson & Johnson's Procrit, in most cancer...To view the full article, register now.
Already a subscriber? Click here to view full article